The Role of Mirena (Intra-uterine progestogens), Other than Contraceptive benefits: Current Concepts and Practices
This paper reviews Mirena's non-contraceptive benefits, including treatment for menorrhagia, endometrial protection during hormone replacement therapy, and potential effects on fibroids, endometriosis, adenomyosis, and endometrial hyperplasia.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This paper reviews current concepts and practices for Mirena, a levonorgestrel-releasing intrauterine system (LNG-IUS), focusing on noncontraceptive benefits and related effects on the endometrium. It describes how LNG thins the endometrium, reduces endometrial gland activity, and may cause early unscheduled bleeding, with functional ovarian cysts noted as a common transient possibility; it also notes differing evidence for use in fibroid uterus, while reporting reductions in fibroid-related menstrual blood loss. It states that Mirena is licensed for menorrhagia with marked blood-loss reduction, provides endometrial protection during hormone replacement therapy, reduces endometrial hyperplasia, and may be used in some early endometrial cancer situations, with lower rates of ectopic pregnancy and pelvic inflammatory disease compared with IUCD users. The paper reports beneficial effects of LNG-IUS in endometriosis and adenomyosis by reducing pain and blood loss, making it directly relevant to those conditions.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
2,556 characters
· extracted from
oa-doi-fallback
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
References (13)
- A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia via openalex
- Levonorgestrel‐releasing intrauterine device in the treatment of menorrhagia via openalex
- W1971184127 via openalex
- W2021595766 via openalex
- W2042374015 via openalex
- W2048255951 via openalex
- W2130961723 via openalex
- W2140370772 via openalex
- W2480729939 via openalex
- W4245653347 via openalex
- W575265418 via openalex
- W4247485700 via openalex
- W1968400287 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00